Neurosteroids as regenerative agents in the brain: therapeutic implications (original) (raw)

• Baulieu, E. E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52, 1–32 (1997).
  CAS PubMed Google Scholar
• Baulieu, E. E. & Schumacher, M. Neurosteroids, with special reference to the effect of progesterone on myelination in peripheral nerves. Mult. Scler. 3, 105–112 (1997).
  Article CAS PubMed Google Scholar
• Melcangi, R. C. & Panzica, G. Neuroactive steroids: an update of their roles in central and peripheral nervous system. Psychoneuroendocrinology 34 (Suppl 1), S1–S8 (2009).
  Article CAS PubMed Google Scholar
• Mellon, S. H. & Griffin, L. D. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13, 35–43 (2002).
  Article CAS PubMed Google Scholar
• Bishop, N. A., Lu, T. & Yankner, B. A. Neural mechanisms of ageing and cognitive decline. Nature 464, 529–535 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Skovronsky, D. M., Lee, V. M. & Trojanowski, J. Q. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1, 151–170 (2006).
  Article CAS PubMed Google Scholar
• Encinas, J. M. et al. Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus. Cell Stem Cell 8, 566–579 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kuhn, H. G., Dickinson-Anson, H. & Gage, F. H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci. 16, 2027–2033 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Lazarov, O., Mattson, M. P., Peterson, D. A., Pimplikar, S. W. & van Praag, H. When neurogenesis encounters aging and disease. Trends Neurosci. 33, 569–579 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Lugert, S. et al. Quiescent and active hippocampal neural stem cells with distinct morphologies respond selectively to physiological and pathological stimuli and aging. Cell Stem Cell 6, 445–456 (2010).
  Article CAS PubMed Google Scholar
• Lugert, S. & Taylor, V. Neural stem cells: disposable, end-state glia? Cell Stem Cell 8, 464–465 (2011).
  Article CAS PubMed Google Scholar
• Singh, C. et al. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3×TgAD and nonTg mice. Neurobiol. Aging 33, 1493–1506 (2012).
  Article CAS PubMed Google Scholar
• Wang, J. M. et al. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 107, 6498–6503 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Rodriguez, J. J. et al. Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLoS ONE 3, e2935 (2008).
  Article PubMed PubMed Central Google Scholar
• Brinton, R. D. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci. 31, 529–537 (2008).
  Article CAS PubMed Google Scholar
• Brinton, R. D. Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends Pharmacol. Sci. 30, 212–222 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Naylor, J. C. et al. Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects. Biochim. Biophys. Acta 1801, 951–959 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, S. Y., He, X. Y. & Schulz, H. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase. Trends Endocrinol. Metab. 16, 167–175 (2005).
  Article CAS PubMed Google Scholar
• Herrup, K. & Yang, Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat. Rev. Neurosci. 8, 368–378 (2007).
  Article CAS PubMed Google Scholar
• Schumacher, M. et al. Progesterone synthesis in the nervous system: implications for myelination and myelin repair. Front. Neurosci. 6, 10 (2012).
  Article PubMed PubMed Central Google Scholar
• Sun, C. et al. Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease. Curr. Alzheimer Res. 9, 473–480 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, J. M., Johnston, P. B., Ball, B. G. & Brinton, R. D. The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J. Neurosci. 25, 4706–4718 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Melcangi, R. C. et al. Role of neuroactive steroids in the peripheral nervous system. Front. Endocrinol. (Lausanne) 2, 104 (2011).
  Article Google Scholar
• Deng, W., Saxe, M. D., Gallina, I. S. & Gage, F. H. Adult-born hippocampal dentate granule cells undergoing maturation modulate learning and memory in the brain. J. Neurosci. 29, 13532–13542 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Rodriguez, J. J., Jones, V. C. & Verkhratsky, A. Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model. Neuroreport 20, 907–912 (2009).
  Article CAS PubMed Google Scholar
• Haughey, N. J. et al. Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. Neuromolecular Med. 1, 125–135 (2002).
  Article CAS PubMed Google Scholar
• Aimone, J. B., Deng, W. & Gage, F. H. Resolving new memories: a critical look at the dentate gyrus, adult neurogenesis, and pattern separation. Neuron 70, 589–596 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Deng, W., Aimone, J. B. & Gage, F. H. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat. Rev. Neurosci. 11, 339–350 (2010).
  CAS PubMed PubMed Central Google Scholar
• Shors, T. J., Townsend, D. A., Zhao, M., Kozorovitskiy, Y. & Gould, E. Neurogenesis may relate to some but not all types of hippocampal-dependent learning. Hippocampus 12, 578–584 (2002).
  Article PubMed PubMed Central Google Scholar
• Shors, T. J. et al. Neurogenesis in the adult is involved in the formation of trace memories. Nature 410, 372–376 (2001).
  Article CAS PubMed Google Scholar
• Bartzokis, G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 32, 1341–1371 (2011).
  Article CAS PubMed Google Scholar
• Kuczynski, B. et al. White matter integrity and cortical metabolic associations in aging and dementia. Alzheimers Dement. 6, 54–62 (2010).
  Article PubMed PubMed Central Google Scholar
• Ringman, J. M. et al. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain 130, 1767–1776 (2007).
  Article PubMed Google Scholar
• Yao, J., Rettberg, J. R., Klosinski, L. P., Cadenas, E. & Brinton, R. D. Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. Mol. Aspects Med. 32, 247–257 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Chen, S. et al. Allopregnanolone promotes regeneration and reduces beta-amyloid burden in a preclinical model of Alzheimer's disease. PLoS ONE 6, e24293 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Desai, M. K. et al. Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 57, 54–65 (2009).
  Article PubMed PubMed Central Google Scholar
• Saher, G. et al. High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8, 468–475 (2005).
  Article CAS PubMed Google Scholar
• Rupprecht, R. et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 9, 971–988 (2010).
  Article CAS PubMed Google Scholar
• Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795–804 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Reitz, C., Brayne, C. & Mayeux, R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 7, 137–152 (2011).
  Article PubMed PubMed Central Google Scholar
• Jack, C. R. Jr. et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119–128 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Reiman, E. M. & Jagust, W. J. Brain imaging in the study of Alzheimer's disease. Neuroimage 61, 505–516 (2012).
  Article PubMed Google Scholar
• Weiner, M. W. et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers. Dement. 8 (Suppl 1) S1–68 (2012).
  Article PubMed Google Scholar
• Lesne, S. et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352–357 (2006).
  Article CAS PubMed Google Scholar
• De Strooper, B., Vassar, R. & Golde, T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 6, 99–107 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Irwin, R. W., Wang, J. M., Chen, S. & Brinton, R. D. Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease. Front. Endocrinol. (Lausanne) 2, 117 (2011).
  Google Scholar
• Kang, J. & Rivest, S. Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors. Endocr. Rev. 33, 2011–1049 (2012).
  Article Google Scholar
• Mandrekar-Colucci, S., Karlo, J. C. & Landreth, G. E. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J. Neurosci. 32, 10117–10128 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Repa, J. J. et al. Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse. J. Neurosci. 27, 14470–14480 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Cramer, P. E. et al. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335, 1503–1506 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Riddell, D. R. et al. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Mol. Cell Neurosci. 34 621–628 (2007).
  Article CAS PubMed Google Scholar
• Langmade, S. J. et al. Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc. Natl Acad. Sci. USA 103, 13807–13812 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kliewer, S. A. & Willson, T. M. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J. Lipid Res. 43, 359–364 (2002).
  CAS PubMed Google Scholar
• Willson, T. M. & Kliewer, S. A. PXR, CAR and drug metabolism. Nat. Rev. Drug Discov. 1, 259–266 (2002).
  Article CAS PubMed Google Scholar
• Porter, F. D. et al. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci. Transl. Med. 2, 56ra81 (2010).
  Article PubMed PubMed Central Google Scholar
• Hagemeyer, C. E., Rosenbrock, H., Ditter, M., Knoth, R. & Volk, B. Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience 117, 521–529 (2003).
  Article CAS PubMed Google Scholar
• Bengtsson, S. K., Johansson, M., Backstrom, T. & Wang, M. Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AbetaPP(Swe)PSEN1(DeltaE9) mice. J. Alzheimers Dis. 31, 71–84 (2012).
  Article CAS PubMed Google Scholar
• Zampieri, S. et al. Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone. J. Cell. Mol. Med. 13, 3786–3796 (2009).
  Article PubMed Google Scholar
• He, J., Hoffman, S. W. & Stein, D. G. Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor. Neurol. Neurosci. 22, 19–31 (2004).
  CAS PubMed Google Scholar
• Noorbakhsh, F. et al. Impaired neurosteroid synthesis in multiple sclerosis. Brain 134, 2703–2721 (2011).
  Article PubMed PubMed Central Google Scholar
• Griffin, L. D., Gong, W., Verot, L. & Mellon, S. H. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat. Med. 10, 704–711 (2004).
  Article CAS PubMed Google Scholar
• Adeosun, S. O. et al. Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease. PLoS ONE 7, e50040 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gee, K. W., Bolger, M. B., Brinton, R. E., Coirini, H. & McEwen, B. S. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 246, 803–812 (1988).
  CAS PubMed Google Scholar
• Reddy, D. S. & Rogawski, M. A. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 6, 392–401 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Belelli, D. & Lambert, J. J. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 6, 565–575 (2005).
  Article CAS PubMed Google Scholar
• Kask, K., Backstrom, T., Nilsson, L. G. & Sundstrom-Poromaa, I. Allopregnanolone impairs episodic memory in healthy women. Psychopharmacology (Berl) 199, 161–168 (2008).
  Article CAS Google Scholar
• ClinicalTrials.gov. Allopregnanolone for the Treatment of Traumatic Brain Injury [online], (2012).
• Sperling, R. et al. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 11, 241–249 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Sperling, R. A. et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimer's Dement. 7, 367–385 (2011).
  Article Google Scholar
• Alzheimer Research Forum. CTAD: New Data on Sola, Bapi, Spark Theragnostics Debate [online], (2012).
• Alzheimer Research Forum. Phase 3 Solanezumab Trials “Fail”—Is There a Silver Lining? [online], (2012).
• Alzheimer Research Forum. Drugs In Clinical Trials [online], (2012).
• Eriksson, P. S. et al. Neurogenesis in the adult human hippocampus. Nat. Med. 4, 1313–1317 (1998).
  Article CAS PubMed Google Scholar
• Hosie, A. M., Wilkins, M. E., da Silva, H. M. & Smart, T. G. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444, 486–489 (2006).
  Article CAS PubMed Google Scholar
• Wang, J. M. & Brinton, R. D. Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential. BMC Neurosci. 9 (Suppl 2), 2–11 (2008).
  Article Google Scholar
• Manganas, L. N. et al. Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science 318, 980–985 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Pereira, A. C. et al. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc. Natl. Acad. Sci. USA 104, 5638–5643 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
  Article CAS PubMed Google Scholar